07.30.12
Quanticate has appointed Sally Du Toit as vice president of Pharmacovigilance , and Chris Cramer as vice president of Clinical Data Management.
Ms. Du Toit joins the company from Aptiv Solutions, where she served as director of Pharmacovigilance. She has 27 years of industry experience including serving as a Deputy QPPV. Ms. Du Toit will lead an experienced team of staff to support client needs.
Ms. Cramer has joins the company from PharmaNet, where she was responsible for European data management operations. She has more than 25 years of experience in the CRO and pharmaceutical industries, and specific knowledge within late phase trials and electronic data capture solutions.
“As Quanticate continues to expand, we saw the need to add additional experienced leadership to our Clinical Data Management and Pharmacovigilance groups,” said David Underwood, Quanticate chief executive officer. “With imminent changes in Pharmacovigilance regulations, our recent partnerships with Medidata RAVE and Comprehend Clinical, the launch of our centralized service provision ( CSP ) Solution , expansion of our India facility, the launch of a new corporate website and significant sales growth, 2012 has become an exciting year for us. The addition of Sally and Chris will be of great importance in shaping our service as we continue to grow.
Ms. Du Toit joins the company from Aptiv Solutions, where she served as director of Pharmacovigilance. She has 27 years of industry experience including serving as a Deputy QPPV. Ms. Du Toit will lead an experienced team of staff to support client needs.
Ms. Cramer has joins the company from PharmaNet, where she was responsible for European data management operations. She has more than 25 years of experience in the CRO and pharmaceutical industries, and specific knowledge within late phase trials and electronic data capture solutions.
“As Quanticate continues to expand, we saw the need to add additional experienced leadership to our Clinical Data Management and Pharmacovigilance groups,” said David Underwood, Quanticate chief executive officer. “With imminent changes in Pharmacovigilance regulations, our recent partnerships with Medidata RAVE and Comprehend Clinical, the launch of our centralized service provision ( CSP ) Solution , expansion of our India facility, the launch of a new corporate website and significant sales growth, 2012 has become an exciting year for us. The addition of Sally and Chris will be of great importance in shaping our service as we continue to grow.
